Member State EU/EEA Marketing Authorisation Holder (Invented) name Strength Pharmaceutical Form Route of administration Content (concentration)

Austria GlaxoSmithKline Pharma GmbH, Albert Schweitzer-Gasse 6, A-1140 Wien Fortum 0,5 g - Trockenstechampullen 500mg Powder for injection Intravenous or intramuscular use

Fortum 1 g - Trockenstechampullen 1g Powder for injection Intravenous or intramuscular use

Fortum 2 g - Trockenstechampullen 2 g Powder for injection/infusion Intravenous use

Belgium GlaxoSmithKline s.a. / n.v. Rue du Tilleul 13 1332 Genval Belgium Glazidim 500 mg Powder for solution for Injection For Intravenous or Intramuscular use

Glazidim 1 g Powder for solution for Infusion For intravenous use

Glazidim 1 g Powder for solution for Injection For Intravenous or Intramuscular use

Glazidim 2 g Powder for solution for infusion For intravenous use

Glazidim 2 g Powder for solution for injection For intravenous use

Bulgaria Glaxo Group Ltd. Glaxo Wellcome House, Berkeley avenue, Greenford, Middlesex UB6 0NN, England Fortum 1 g Powder for solution for Injection For intravenous or intramuscular use

Cyprus Glaxo Group Limited Berkeley Avenue Greenford Middlex UB6 0NN United Kingdom Fortum 1 g Powder for Injection For intravenous use Vials contain 1g ceftazidime (as pentahydrate)

Czech Republic Glaxo Group Ltd., Glaxo Welcome House, Berkeley avenue, Greenford, Middlesex UB6 0NN United Kingdom Fortum 500mg 500 mg Powder for solution for injection For intravenous use

Fortum 1g 1 g Powder for solution for injection For intravenous use

Fortum 2g 2 g Powder for solution for injection For intravenous use

Denmark GlaxoSmithKline Pharma A/S Nykaer 68, 2605 Broendby Denmark Fortum 500 mg Powder for Injection For intravenous use

Fortum 1 g Powder for Injection For intravenous use

Fortum 2 g Powder for Injection For intravenous use

Estonia Glaxo Wellcome Operations, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN United Kingdom Fortum 1 g Powder for solution for injection /infusion For intramuscular or intravenous use 1g

Finland Glaxo Operations UK Ltd, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN England Glazidim 500 mg Powder for solution for Injection For intramuscular or intravenous use Vials contain 500 mg ceftazidime (as pentahydrate)

Glaxo Operations UK Ltd, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN United Kingdom Glazidim 1 g Powder for solution for injection For intramuscular or intravenous use Vials contain 1 g ceftazidime (as pentahydrate)

GlaxoSmithKline Oy, PB 24, 02231 Espoo Glazidim 1 g Powder for solution for injection/infusion For intramuscular or intravenous use Vials contain 1 g ceftazidime (as pentahydrate)

GlaxoSmithKline Oy, PB 24, 02231 Espoo Finland Glazidim 2 g Powder for solution for injection/infusion For intramuscular or intravenous use Vials contain 2 g ceftazidime (as pentahydrate)

GlaxoSmithKline Oy, PB 24, 02231 Espoo Finland Glazidim 3 g Powder for solution for injection/infusion For intramuscular or intravenous use Vials contain 3 g ceftazidime (as pentahydrate)

France Laboratoire GlaxoSmithKline 100, route de Versailles – 78163 Marly-le-Roi Cedex France Fortum enfants et nourrisons 250 mg Powder for solution for injection For intravenous or intramuscular use 295 mg

Fortum enfants et nourrisons 500 mg Powder for solution for injection For intravenous or intramuscular use 591 mg

Fortumset 1 g Powder for solution for infusion (IV) For intravenous use 1 182 mg

Fortum 1 g Powder for solution for Injection For intravenous or intramuscular use 1 182mg

Fortumset 2 g Powder for solution for infusion (IV) For intravenous use 2 364 mg

Fortum 2 g Powder for solution for injection (IV) For intravenous use 2 364 mg

Germany GlaxoSmithKline GmbH & Co. KG Theresienhöhe 11 80339 München Germany Fortum 500 mg Powder for solution for injection or infusion For intravenous and intramuscular use

Fortum 1 g Powder for solution for injection or infusion For intravenous and intramuscular use

Fortum 2 g Powder for solution for injection or infusion For intravenous use

Greece GlaxoSmithKline a.e.b.e, Leof. Kifissias 266, 152 32 Halandri, Athens Greece Solvetan 1 g Powder for injection For intramuscular or intravenous use

Solvetan 2 g Powder for injection For intravenous use

Hungary GlaxoSmithKline Kft. 1124 Bp, Csörsz u. 43. Hungary Fortum 500 mg Powder for injection For intravenous use

Fortum 1 g Powder for injection For intravenous use

Fortum 2 g Powder for infusion For intravenous use

Iceland GlaxoSmithKline ehf. Thverholt 14 105 Reykjavík Iceland Fortum 1 g Powder for solution for injection For intravenous or intramuscular use

Fortum 2 g Powder for solution for infusion For intravenous use

Ireland GlaxoSmithKline (Ireland) Limited Stonemasons Way, Rathfarnham, Dublin 16 Ireland Fortum 500 mg Powder for solution for injection For intravenous or intramuscular injection Reconstituted solution contains 500mg ceftazidime

Fortum 1 g Powder for solution for injection or infusion, vial For intravenous or intramuscular injection or infusion Reconstituted solution contains 1g ceftazidime

Fortum 1 g Powder for infusion, monovial For infusion Reconstituted solution contains 1g ceftazidime

Fortum 2 g Powder for solution for injection or infusion, vial For intravenous or intramuscular injection or infusion Reconstituted solution contains 2g ceftazidime

Fortum 2 g Powder for infusion, monovial For infusion Reconstituted solution contains 2g ceftazidime

Italy GlaxoSmithKline S.p.A. - Via A. Fleming, 2 – 37135 Verona Italy Glazidim 250 mg/ml Powder and solvent for solution for injection For intramuscular use

Glazidim 500 mg/1,5 ml Powder and solvent for solution for injection For intramuscular use

Glazidim 1 g/3 ml Powder and solvent for solution for injection For intramuscular use

Glazidim 1 g/10 ml Powder and solvent for solution for injection For intravenous use

Glazidim 2 g Powder for solution for infusion For intravenous use

Glazidim 1 g/100 ml Powder and solvent for solution for infusion (Monovial) For intravenous use

Glazidim 2 g/100 ml Powder and solvent for solution for infusion (Monovial) For intravenous use

Glazidim 1 g Powder for solution for infusion (Monovial) For intravenous use

Glazidim 2 g Powder for solution for infusion (Monovial) For intravenous use

Glaxo Allen S.p.A Via Fleming, 2 Verona Italy Panzid 1 g/3 ml Powder and solvent for solution for injection For intramuscular use

Latvia GlaxoSmithKline Latvia SIA Bruninieku 5, Riga, LV-1001, Latvia Fortum 1 g powder for solution for injection or infusion 1 g Powder for solution for injection or infusion For intravenous use or intramuscular use 1 g ceftazidime (as ceftazidime pentahydrate)

Lithuania UAB „GlaxoSmithKline Lietuva“, A. Goštauto g. 40A, LT-01112 Vilnius, Lithuania Fortum 500 mg Powder and solvent for solution for injection Intravenous use or intramuscular use

Fortum 1 g Powder and solvent for solution for injection Intravenous use or intramuscular use

Fortum 2 g Powder for solution for injection or infusion Intravenous use

Fortum 3 g Powder for solution for injection or infusion Intravenous use

Luxembourg GlaxoSmithKline s.a. / n.v. Rue du Tilleul 13 1332 Genval Belgium Glazidim 500 mg Powder for solution for injection For Intravenous or Intramuscular use

Glazidim 1 g Powder for solution for infusion For intravenous use

Glazidim 1 g Powder for solution for injection For Intravenous or Intramuscular use

Glazidim 2 g Powder for solution for infusion For intravenous use

Glazidim 2 g Powder for solution for injection For intravenous use

Malta Glaxo Operations UK Limited Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN United Kingdom Fortum 1g per vial Powder for solution for injection For intravenous or Intramuscular use

Netherlands Glaxo Smith Kline B.V. Huis ter Heideweg 62 3705 LZ ZEIST THE NETHERLANDS Fortum 500 mg Powder for solution for injection For intravenous or intramuscular use

Fortum 1 g Powder for solution for injection For intravenous or intramuscular use

Fortum 2 g Powder for solution for injection For intravenous use

Norway GlaxoSmithKline AS Forskningsveien 2A Postboks 180 Vinderen 0319 Oslo Norway Fortum 500 mg Powder for infusion/injection For intravenous or intramuscular use

Fortum 1 g Powder for infusion/injection For intravenous or intramuscular use

Fortum 2 g Powder for infusion/injection For intravenous use

Poland GlaxoSmithKline Export Ltd 980 Great West Road Brentford, Middlesex, TW8 9GS United Kingdom Fortum 250 mg Powder for solution for injection For intramuscular or intravenous use

Fortum 500 mg Powder for solution for injection For intramuscular or intravenous use

Fortum 1 g Powder for solution for injection and infusion For intramuscular or intravenous use

Fortum 2 g Powder solution for injection and infusion For intravenous use

Portugal Glaxo Wellcome Farmacêutica, Lda. Rua Dr. António Loureiro Borges, 3 Aquiparque – Miraflores 1495 – 131 Algés Portugal Cefortam 500 mg/1,5 ml Powder and solvent for solution for injection For intravenous or intramuscular use

Cefortam 1 g/3 ml Powder and solvent for solution for injection For intravenous or intramuscular use

Cefortam 2 g Powder for solution for injection For intravenous use

Romania Glaxo Wellcome UK Limited, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN United Kingdom Fortum 500 mg Powder for injection For intravenous or intramuscular use

Fortum 1 g Powder for injection For intravenous or intramuscular use

Fortum 1 g Powder for injection For intravenous or intramuscular use

Fortum 1 g Powder for injection For intravenous or intramuscular use

Fortum 2 g Powder for injection or infusion For intravenous or intramuscular use

Slovak Republic GlaxoSmithKline Slovakia sro., Galvaniho7/A, 82104 Bratislava, Slovakia. Fortum 500 mg Powder for injection For intravenous use

Fortum 1 g Powder for infusion For intravenous use

Fortum 2 g Powder for infusion For intravenous use

Slovenia GSK d.o.o., Ljubljana Knezov štradon 90 SI-1000 Ljubljana Slovenija Fortum 1 g Powder for injection or infusion For intravenous use

Fortum Monovial 1 g Powder for infusion For intravenous use

Spain GlaxoSmithKline, S.A. P.T.M.- C/Severo Ochoa, 2 28760 Tres Cantos (Madrid) Spain Fortam IM/IV 500 mg Powder for injection For intravenous use/IM

Fortam IV 1 g Powder for injection For intravenous use

Fortam 1 g 1 g Powder for injection For intravenous use/IM

Fortam IV 2 g Powder for infusion For intravenous use

Sweden GlaxoSmithKline AB Box 516 169 29 Solna Sweden Fortum 250 mg Powder for solution for injection For intramuscular or intravenous use 250 mg ceftazidime (as pentahydrate)

Fortum 500 mg Powder for solution for injection For intramuscular or intravenous use 500 mg ceftazidime (as pentahydrate)

Fortum 1 g Powder for solution for injection For intramuscular or intravenous use 1 g ceftazidime (as pentahydrate)

Fortum 1 g Powder for solution for infusion For intravenous use 1 g ceftazidime (as pentahydrate)

Fortum 1 g Monovial Powder for solution for infusion For intravenous use 1 g ceftazidime (as pentahydrate)

Fortum 2 g Monovial Powder for solution for infusion For intravenous use 2 g ceftazidime (as pentahydrate)

Fortum 2 g Powder for solution for injection/infusion For intravenous use 2 g ceftazidime (as pentahydrate)

United Kingdom Glaxo Operations UK Ltd, Glaxo Wellcome House, Berkeley Avenue, Greenford Road, Middlesex, UB6 0NN United Kingdom Fortum 250 mg Powder for injection intravenous use and intramuscular use 118 mg per gram of ceftazidime

Fortum 500 mg Powder for injection intravenous use and intramuscular use 118 mg per gram of ceftazidime

Fortum 1 g Powder for injection intravenous use and intramuscular use 118 mg per gram of ceftazidime